Clone of IPG604 Aortic valve reconstruction with processed bovine pericardiumProduct type:GuidanceProgramme:HealthTech guidanceExpected publication date: 14 February 2018
Clone of IPG613 Percutaneous balloon valvuloplasty for fetal critical aortic stenosisProduct type:GuidanceProgramme:HealthTech guidanceExpected publication date: 9 May 2018
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation (HTG772)Product type:GuidanceProgramme:HealthTech guidancePublished: 18 March 2026
Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitation (HTG771)Product type:GuidanceProgramme:HealthTech guidancePublished: 25 February 2026
Acoramidis for treating transthyretin amyloidosis with cardiomyopathy (TA1121)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 January 2026
Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy (TA1115)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 10 December 2025
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 29 July 2026
Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [ID6759]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Elamipretide for treating Barth syndrome in people of any age [ID6545]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Aficamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6668]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Heart valve disease presenting in adults: investigation and management - transcatheter aortic valve implantation (TAVI) to treat aortic stenosis (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC